ALS United Mid-Atlantic Unites ALS Research Leaders

Investing in research means investing in future successful treatments for all forms of ALS. Your donations and advocacy make it possible for ALS United Mid-Atlantic to support vital research programs that are making progress towards understanding the disease while empowering those living with ALS to be part of important trials and studies.

In July 2025, the board of ALS United Mid-Atlantic approved funding for these promising research projects:

• Jefferson Weinberg ALS Center: Novel Microglia-Targeted CAR-T Therapy for ALS: Preclinical Evaluation in Mice and Patient Organoids
• Penn State Health Hershey Medical Center: Metabolic Biomarkers in ALS
• ALS TDI: Acquisition of an ELISA platform, with 384-well plate capacity
• Temple University: Cellular-level transcriptional pathway alterations for selection of blood biomarkers of C9orf72 ALS

In addition to direct funding of ongoing research, ALS United Mid-Atlantic continues to connect people with ALS to local projects, and educates the wider community about ALS research through the GOALS Podcast and on YouTube. ALS United Mid-Atlantic also toured the research facilities at the Jefferson Weinberg ALS Certified Treatment Center of Excellence at Thomas Jefferson University Hospital and the ALS Certified Treatment Center of Excellence at Penn State Health Milton S. Hershey Medical Center to see their advances in research studies and how these remarkable scientists are collaborating and producing groundbreaking results.

To learn more about our commitment to research, visit www.ALSMidAtlantic.org.